Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa
Philip Low looks to validate previous trial results and test whether the number of days of an anti-malaria drug therapy can be reduced WEST LAFAYETTE, Ind. – A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries. Open Philanthropy has awarded $1.38 million to Philip…
Read the Research